Investegate announcements from Sartorius Stedim Biotech SA, René Fáber takes over as Chief Executive Officer of Sartorius Stedim Biotech S.A.; Joachim Kreuzburg remains Chairman of the Board
Investegate announcements from Sartorius Stedim Biotech SA, Board of Directors of Sartorius Stedim Biotech resolves to propose a dividend of 1.44 euros per share to the Annual Shareholders’ Meeting
Sales revenue of 3,493 million euros, in constant currencies1 up 13.2 percent organically1 and up 15.1 percent including acquisitions (reported: up 21.0.
/PRNewswire/ Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, has agreed to acquire 100 percent of Albumedix Ltd..